Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

This article presents a comprehensive genetic, clinical, and drug sensitivity analysis of a large series of B-prolymphocytic leukemia cases, illustrating new fi

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Chapiro, Elise (VerfasserIn) , Wagner, Lena (VerfasserIn) , Scheinost, Sebastian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 16 September 2019
In: Blood
Year: 2019, Jahrgang: 134, Heft: 21, Pages: 1821-1831
ISSN:1528-0020
DOI:10.1182/blood.2019001187
Online-Zugang:Verlag, Volltext: https://doi.org/10.1182/blood.2019001187
Verlag, Volltext: https://ashpublications.org/blood/article/134/21/1821/374989/Genetic-characterization-of-B-cell-prolymphocytic
Volltext
Verfasserangaben:Elise Chapiro, Elodie Pramil, M’boyba Diop, Damien Roos-Weil, Clémentine Dillard, Clémentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-François Lesesve, Mélanie Yon, Ludovic Jondreville, Claude Lesty, Frédéric Davi, Magali Le Garff-Tavernier, Nathalie Droin, Philippe Dessen, Caroline Algrin, Véronique Leblond, Jean Gabarre, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, Christine Lefebvre, Nathalie Nadal, Antoine Ittel, Stéphanie Struski, Marie-Agnès Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, Santos A. Susin, Olivier A. Bernard, and Florence Nguyen-Khac, for the GroupeFrancophone de Cytog ́en ́etique H ́ematologique (GFCH) and the French Innovative Leukemia Organization (FILO)

MARC

LEADER 00000caa a2200000 c 4500
001 1688141030
003 DE-627
005 20230426072902.0
007 cr uuu---uuuuu
008 200123s2019 xx |||||o 00| ||eng c
024 7 |a 10.1182/blood.2019001187  |2 doi 
035 |a (DE-627)1688141030 
035 |a (DE-599)KXP1688141030 
035 |a (OCoLC)1341298870 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Chapiro, Elise  |e VerfasserIn  |0 (DE-588)1203319533  |0 (DE-627)168814241X  |4 aut 
245 1 0 |a Genetic characterization of B-cell prolymphocytic leukemia  |b a prognostic model involving MYC and TP53  |c Elise Chapiro, Elodie Pramil, M’boyba Diop, Damien Roos-Weil, Clémentine Dillard, Clémentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-François Lesesve, Mélanie Yon, Ludovic Jondreville, Claude Lesty, Frédéric Davi, Magali Le Garff-Tavernier, Nathalie Droin, Philippe Dessen, Caroline Algrin, Véronique Leblond, Jean Gabarre, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, Christine Lefebvre, Nathalie Nadal, Antoine Ittel, Stéphanie Struski, Marie-Agnès Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, Santos A. Susin, Olivier A. Bernard, and Florence Nguyen-Khac, for the GroupeFrancophone de Cytog ́en ́etique H ́ematologique (GFCH) and the French Innovative Leukemia Organization (FILO) 
264 1 |c 16 September 2019 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.01.2020 
500 |a Im Titel sind "MYC" und "TP53" kursiv geschrieben 
520 |a This article presents a comprehensive genetic, clinical, and drug sensitivity analysis of a large series of B-prolymphocytic leukemia cases, illustrating new fi 
700 1 |a Wagner, Lena  |e VerfasserIn  |0 (DE-588)1171497334  |0 (DE-627)1040567320  |0 (DE-576)513766464  |4 aut 
700 1 |a Scheinost, Sebastian  |e VerfasserIn  |0 (DE-588)1203319711  |0 (DE-627)168814305X  |4 aut 
773 0 8 |i Enthalten in  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 134(2019), 21, Seite 1821-1831  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnas  |a Genetic characterization of B-cell prolymphocytic leukemia a prognostic model involving MYC and TP53 
773 1 8 |g volume:134  |g year:2019  |g number:21  |g pages:1821-1831  |g extent:11  |a Genetic characterization of B-cell prolymphocytic leukemia a prognostic model involving MYC and TP53 
856 4 0 |u https://doi.org/10.1182/blood.2019001187  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://ashpublications.org/blood/article/134/21/1821/374989/Genetic-characterization-of-B-cell-prolymphocytic  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20200123 
993 |a Article 
994 |a 2019 
998 |g 1203319711  |a Scheinost, Sebastian  |m 1203319711:Scheinost, Sebastian  |d 50000  |e 50000PS1203319711  |k 0/50000/  |p 36 
998 |g 1171497334  |a Wagner, Lena  |m 1171497334:Wagner, Lena  |p 35 
999 |a KXP-PPN1688141030  |e 357914135X 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"recId":"1688141030","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 23.01.2020","Im Titel sind \"MYC\" und \"TP53\" kursiv geschrieben"],"person":[{"given":"Elise","family":"Chapiro","role":"aut","roleDisplay":"VerfasserIn","display":"Chapiro, Elise"},{"display":"Wagner, Lena","roleDisplay":"VerfasserIn","role":"aut","family":"Wagner","given":"Lena"},{"family":"Scheinost","given":"Sebastian","roleDisplay":"VerfasserIn","display":"Scheinost, Sebastian","role":"aut"}],"title":[{"title_sort":"Genetic characterization of B-cell prolymphocytic leukemia","subtitle":"a prognostic model involving MYC and TP53","title":"Genetic characterization of B-cell prolymphocytic leukemia"}],"relHost":[{"disp":"Genetic characterization of B-cell prolymphocytic leukemia a prognostic model involving MYC and TP53Blood","note":["Gesehen am 21.04.2023"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"266886647","corporate":[{"display":"American Society of Hematology","roleDisplay":"Herausgebendes Organ","role":"isb"}],"language":["eng"],"pubHistory":["1.1946 -"],"part":{"year":"2019","issue":"21","pages":"1821-1831","volume":"134","text":"134(2019), 21, Seite 1821-1831","extent":"11"},"titleAlt":[{"title":"Blood online"}],"title":[{"title_sort":"Blood","subtitle":"journal of the American Society of Hematology","title":"Blood"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","dateIssuedDisp":"1946-","dateIssuedKey":"1946","publisher":"American Society of Hematology ; Saunders ; HighWire Press"}],"id":{"eki":["266886647"],"zdb":["1468538-3"],"issn":["1528-0020"]}}],"physDesc":[{"extent":"11 S."}],"name":{"displayForm":["Elise Chapiro, Elodie Pramil, M’boyba Diop, Damien Roos-Weil, Clémentine Dillard, Clémentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-François Lesesve, Mélanie Yon, Ludovic Jondreville, Claude Lesty, Frédéric Davi, Magali Le Garff-Tavernier, Nathalie Droin, Philippe Dessen, Caroline Algrin, Véronique Leblond, Jean Gabarre, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, Christine Lefebvre, Nathalie Nadal, Antoine Ittel, Stéphanie Struski, Marie-Agnès Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, Santos A. Susin, Olivier A. Bernard, and Florence Nguyen-Khac, for the GroupeFrancophone de Cytog ́en ́etique H ́ematologique (GFCH) and the French Innovative Leukemia Organization (FILO)"]},"id":{"doi":["10.1182/blood.2019001187"],"eki":["1688141030"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"16 September 2019"}]} 
SRT |a CHAPIROELIGENETICCHA1620